BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 22398803)

  • 1. Acquired hemophilia a: a current review of autoantibody disease.
    Sborov DW; Rodgers GM
    Clin Adv Hematol Oncol; 2012 Jan; 10(1):19-27. PubMed ID: 22398803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How I manage patients with acquired haemophilia A.
    Sborov DW; Rodgers GM
    Br J Haematol; 2013 Apr; 161(2):157-65. PubMed ID: 23373521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired hemophilia: a case report of 2 patients with acquired factor VIII inhibitor treated with rituximab plus a short course of steroid and review of the literature.
    Alvarado Y; Yao X; Jumper C; Hardwicke F; D'Cunha N; Cobos E
    Clin Appl Thromb Hemost; 2007 Oct; 13(4):443-8. PubMed ID: 17911199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired hemophilia a: diagnosis, aetiology, clinical spectrum and treatment options.
    Shetty S; Bhave M; Ghosh K
    Autoimmun Rev; 2011 Apr; 10(6):311-6. PubMed ID: 21115138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired hemophilia in the patient suffering from rheumatoid arthritis: case report.
    Drobiecki A; Pasiarski M; Hus I; Sokołowska B; Wątek M
    Blood Coagul Fibrinolysis; 2013 Dec; 24(8):874-80. PubMed ID: 24042266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired hemophilia A: a concise review.
    Franchini M; Gandini G; Di Paolantonio T; Mariani G
    Am J Hematol; 2005 Sep; 80(1):55-63. PubMed ID: 16138334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent improvements in the clinical treatment of coagulation factor inhibitors.
    Franchini M; Lippi G
    Semin Thromb Hemost; 2009 Nov; 35(8):806-13. PubMed ID: 20169517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunosuppressive treatment of a spontaneous inhibitor hemophilia A using cyclophosphamide, vincristine and prednisone following prior Factor VIII stimulation].
    Dürig J; de Wit M; Fiedler W; Marx G; Hossfeld DK
    Schweiz Med Wochenschr; 1996 Nov; 126(47):2026-31. PubMed ID: 8984611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New protocol for immune tolerance induction in acquired hemophilia.
    Nemes L; Pitlik E
    Haematologica; 2000 Oct; 85(10 Suppl):64-8. PubMed ID: 11187874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current management of acquired factor VIII inhibitors.
    Barnett B; Kruse-Jarres R; Leissinger CA
    Curr Opin Hematol; 2008 Sep; 15(5):451-5. PubMed ID: 18695367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory, clinical and therapeutic aspects of acquired hemophilia A.
    Franchini M; Targher G; Montagnana M; Lippi G
    Clin Chim Acta; 2008 Sep; 395(1-2):14-8. PubMed ID: 18505682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acquired hemophilia caused by autoantibodies against factor VIII coagulation activity. Clinical, biological study and therapeutic indications. Experience based on a study of 9 cases].
    Liozon E; Delaire L; Turlure P; Jaccard A; Loustaud-Ratti V; Réméniéras L; Julia A; Gaillard S; Bordessoule D; Vidal E
    Ann Med Interne (Paris); 1997; 148(7):477-90. PubMed ID: 9538386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquired hemophilia: a case report and review of the literature.
    Mulliez SM; Vantilborgh A; Devreese KM
    Int J Lab Hematol; 2014 Jun; 36(3):398-407. PubMed ID: 24750687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiopathic factor VIII inhibitor autoantibody in a man presented after accident.
    Mansouritorghabeh H; Lak M; van Heerde WL
    Clin Appl Thromb Hemost; 2009 Oct; 15(5):588-90. PubMed ID: 18550586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term response to rituximab in a patient with acquired hemophilia].
    García-Chávez J; Vela-Ojeda J; García-Manzano A; Majluf-Cruz A
    Rev Invest Clin; 2011; 63(2):210-2. PubMed ID: 21717725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired hemophilia A.
    Franchini M
    Hematology; 2006 Apr; 11(2):119-25. PubMed ID: 16753853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitor antibodies to factor VIII and factor IX: management.
    Lusher JM
    Semin Thromb Hemost; 2000; 26(2):179-88. PubMed ID: 10919411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acquired haemophilia A].
    Smejkal P; Buliková A; Chlupová G; Zavřelová J
    Vnitr Lek; 2012; 58(7-8):571-8. PubMed ID: 23067181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired factor VIII inhibitors in oncohematology: a systematic review.
    Franchini M; Targher G; Manzato F; Lippi G
    Crit Rev Oncol Hematol; 2008 Jun; 66(3):194-9. PubMed ID: 18243727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical heterogeneity of acquired hemophilia A: a description of 4 cases.
    Franchini M; Girelli D; Olivieri O; Bozzini C; Guiotto M; Zardini G; Lippi G; Manzato F; Gandin G
    Haematologica; 2005 Mar; 90(3):ECR16. PubMed ID: 15753057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.